Pulmonx Corp (LUNG)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
In fiscal 2025, Pulmonx Corp reported revenue of $90.50M, up 8.0% from the prior year. The company ran a net loss, with a net margin of -59.7% and a gross margin of 74.2%. It held $129.29M in total assets against $75.17M in total liabilities.
Key ratios (FY2025)
74.2%
Gross margin
-59.3%
Operating margin
-59.7%
Net margin
-99.8%
Return on equity
+8.0%
Revenue growth (YoY)
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $90.50M | $83.79M | $68.67M | $53.66M | $48.42M | $32.73M | $32.59M | $20.00M | — |
| Cost of Revenue | $23.36M | $21.79M | $17.92M | $13.80M | $12.79M | $11.53M | $10.18M | $7.72M | — |
| Gross Profit | $67.14M | $62.00M | $50.75M | $39.87M | $35.63M | $21.20M | $22.41M | $12.29M | — |
| Operating Income | -$53.66M | -$57.70M | -$61.94M | -$58.64M | -$47.30M | -$32.33M | -$17.84M | -$15.05M | — |
| Net Income | -$54.00M | -$56.39M | -$60.84M | -$58.92M | -$48.66M | -$32.23M | -$20.70M | -$18.48M | — |
| EPS (Diluted) | $-1.33 | $-1.44 | $-1.60 | $-1.59 | $-1.35 | $-3.16 | — | — | — |
| Total Assets | $129.29M | $162.85M | $177.78M | $193.68M | $235.17M | $263.71M | $53.53M | — | — |
| Total Liabilities | $75.17M | $77.04M | $59.47M | $39.67M | $41.93M | $37.57M | $35.57M | — | — |
| Shareholders' Equity | $54.12M | $85.81M | $118.31M | $154.01M | $193.24M | $226.13M | -$187.38M | -$167.33M | -$149.39M |
| Cash & Equivalents | $69.75M | $70.91M | $83.55M | $101.74M | $148.48M | $231.56M | $14.77M | $4.12M | — |
| Operating Cash Flow | -$32.38M | -$31.54M | -$37.61M | -$45.08M | -$41.39M | -$30.63M | -$20.77M | -$18.39M | — |
| Capital Expenditures | $452.0K | $1.45M | $807.0K | $1.32M | $3.67M | $911.0K | $720.0K | $316.0K | — |
| Shares Outstanding | 41.67M | 39.79M | 38.52M | 37.56M | 36.93M | 35.69M | 2.10M | — | — |